BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21107851)

  • 1. Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future.
    Parchi P; Strammiello R; Giese A; Kretzschmar H
    Acta Neuropathol; 2011 Jan; 121(1):91-112. PubMed ID: 21107851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebral distribution of the abnormal isoform of the prion protein in sporadic Creutzfeldt-Jakob disease and fatal insomnia.
    Parchi P; Capellari S; Gambetti P
    Microsc Res Tech; 2000 Jul; 50(1):16-25. PubMed ID: 10871544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic variability in human prion diseases.
    Ironside JW; Ritchie DL; Head MW
    Neuropathol Appl Neurobiol; 2005 Dec; 31(6):565-79. PubMed ID: 16281905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biology and pathology of prion strains in sporadic human prion diseases.
    Gambetti P; Cali I; Notari S; Kong Q; Zou WQ; Surewicz WK
    Acta Neuropathol; 2011 Jan; 121(1):79-90. PubMed ID: 21058033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathology, classification, and diagnosis of sporadic human prion disease variants.
    Parchi P; Saverioni D
    Folia Neuropathol; 2012; 50(1):20-45. PubMed ID: 22505361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease.
    Schoch G; Seeger H; Bogousslavsky J; Tolnay M; Janzer RC; Aguzzi A; Glatzel M
    PLoS Med; 2006 Feb; 3(2):e14. PubMed ID: 16354106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis.
    Capellari S; Strammiello R; Saverioni D; Kretzschmar H; Parchi P
    Acta Neuropathol; 2011 Jan; 121(1):21-37. PubMed ID: 20978903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion disease with a 144 base pair insertion: unusual cerebellar prion protein immunoreactivity.
    Gelpi E; Kovacs GG; Ströbel T; Koperek O; Voigtländer T; Liberski PP; Budka H
    Acta Neuropathol; 2005 Nov; 110(5):513-9. PubMed ID: 16155763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human prion diseases: molecular and clinical aspects.
    Glatzel M; Stoeck K; Seeger H; Lührs T; Aguzzi A
    Arch Neurol; 2005 Apr; 62(4):545-52. PubMed ID: 15824251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential solubility of prions is associated in manifold phenotypes.
    Kuczius T; Karch H; Groschup MH
    Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of sporadic Creutzfeldt-Jakob disease revisited.
    Cali I; Castellani R; Yuan J; Al-Shekhlee A; Cohen ML; Xiao X; Moleres FJ; Parchi P; Zou WQ; Gambetti P
    Brain; 2006 Sep; 129(Pt 9):2266-77. PubMed ID: 16923954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular bases of prion diseases].
    Rać M; Rać M
    Ann Acad Med Stetin; 2006; 52(3):5-13. PubMed ID: 17385343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease.
    Jeffrey M; McGovern G; Sisó S; González L
    Acta Neuropathol; 2011 Jan; 121(1):113-34. PubMed ID: 20532540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain Typing of Prion Diseases Using In Vivo Mouse Models.
    Boyle A; Hogan K; Manson JC; Diack AB
    Methods Mol Biol; 2017; 1658():263-283. PubMed ID: 28861795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prion proteins: a biological role beyond prion diseases.
    Hu W; Rosenberg RN; Stüve O
    Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
    Liemann S; Glockshuber R
    Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
    Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical fingerprints of prion diseases: scrapie prion protein in human prion diseases that share prion genotype and type.
    Pan T; Li R; Kang SC; Pastore M; Wong BS; Ironside J; Gambetti P; Sy MS
    J Neurochem; 2005 Jan; 92(1):132-42. PubMed ID: 15606903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxic species in prion disease: a role for PrP isoforms?
    Harrison CF; Barnham KJ; Hill AF
    J Neurochem; 2007 Dec; 103(5):1709-20. PubMed ID: 17944867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered prion protein glycosylation in the aging mouse brain.
    Goh AX; Li C; Sy MS; Wong BS
    J Neurochem; 2007 Feb; 100(3):841-54. PubMed ID: 17144900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.